Can Lente Insulin Be Given BID?
Yes, lente insulin can and should be administered twice daily (BID) in both dogs and cats, as this is the standard dosing regimen for this intermediate-acting insulin formulation.
Dosing Schedule for Lente Insulin
Lente insulin is classified as an intermediate-acting insulin that requires BID administration to provide adequate glycemic control throughout a 24-hour period 1, 2, 3, 4. The pharmacokinetic profile of lente insulin does not provide sufficient duration of action for once-daily dosing in most patients.
Evidence-Based Dosing Practices
In veterinary medicine (where lente insulin remains commonly used):
- Dogs: Lente insulin is administered at 0.25-0.5 IU/kg BID, with a maximum starting dose of 2 IU per injection 5
- Cats: The same BID dosing schedule applies, with 76% of specialists selecting lente insulin administered twice daily in clinical practice 2
- The median dose used by specialists is approximately 0.43 U/kg/injection BID 2
Important Clinical Considerations
Timing and administration:
- Lente insulin should be given at approximately 12-hour intervals
- Each dose should be coordinated with meals to optimize glucose control
- The insulin must be gently mixed (rolled, not shaken) before each injection to ensure uniform suspension 1
Safety profile:
- Hypoglycemia risk increases significantly at doses ≥0.5 IU/kg or ≥3 units per injection 5
- Biochemical hypoglycemia is significantly associated with doses ≥0.75 IU/kg BID 5
- Start conservatively and titrate gradually based on glucose monitoring
Why BID Dosing Is Necessary
Lente insulin's intermediate duration of action (typically 8-14 hours) makes once-daily dosing inadequate for maintaining stable glucose levels throughout the day 3, 4. Unlike true basal insulins (glargine U300, degludec), lente insulin does not provide consistent hour-to-hour action and therefore requires twice-daily administration to prevent periods of inadequate insulin coverage 4.
Mixing Considerations
Critical caveat: When mixing lente insulin with rapid-acting insulins:
- Rapid-acting insulin can be mixed with lente insulin 1
- The mixture should be injected within 15 minutes before a meal 1
- Phosphate-buffered insulins (NPH) should NOT be mixed with lente insulins 1
- Mixing of short-acting and lente insulins is not recommended except for patients already adequately controlled on such a mixture 1
Clinical Monitoring
After initiating BID lente insulin:
- Monitor for clinical signs of hypoglycemia (tremors, weakness, seizures)
- Perform glucose curves to assess adequacy of control
- Adjust doses in small increments (10-20% changes) to avoid hypoglycemia 5
- Reassess every 2-4 weeks during stabilization 5
The BID dosing regimen for lente insulin is well-established, safe when dosed appropriately, and remains the standard of care where this insulin formulation is used 2, 3, 5.